Kinase signaling and targeted therapy for primary myelofibrosis.

导出 OA

翻译打印收藏纠错

作者： Qiong,Yang ^[1] ; John D,Crispino ^[2] ; Qiang Jeremy,Wen ^[3]

作者单位： Beijing Key Laboratory of Gene Resource and Molecular Development, College of Life Sciences, Beijing Normal University, Beijing, China. ^[1] Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, IL. ^[2] Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, IL. Electronic address: q-wen@northwestern.edu. ^[3]

主题词动物(Animals);人类(Humans);Janus激酶类(Janus Kinases);分子靶向治疗(Molecular Targeted Therapy);肌球蛋白类(Myosins);原发性骨髓纤维化(Primary Myelofibrosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白激酶类(Protein Kinases);STAT转录因子类(STAT Transcription Factors);信号传导(Signal Transduction);ρGTP结合蛋白质类(rho GTP-Binding Proteins);rho相关激酶类(rho-Associated Kinases)

DOI 10.1016/j.exphem.2016.12.007

PMID 28043820

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览15

Experimental hematology

2017年48卷

32-38页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Kinase signaling and targeted therapy for primary myelofibrosis.

Experimental hematology

相似文献

Experimental hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Kinase signaling and targeted therapy for primary myelofibrosis.

Experimental hematology

相似文献

Experimental hematology

相关期刊

检索历史清除